Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease
ConclusionsFecal calprotectin may be a useful noninvasive marker to predict adverse pregnancy-related outcomes in patients with IBD.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
More News: Emergency Medicine | Gastroenterology | Induction of Labor | Inflammatory Bowel Disease | Pregnancy | Study | Women